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Background: Piroxicam (PXM) belongs to the wide class of non-steroidal anti-inflammatory drugs (NSAIDs). PXM
has been widely applied in the treatment of rheumatoid arthritis, gonarthrosis, osteoarthritis, backaches, neuralgia,
mialgia. In the presented work, a green and benign sample pretreatment method called temperature-controlled
ionic liquid dispersive liquid phase microextraction (TCIL-DLPME) was followed with stopped-flow injection
spectrofluorimetry (SFIS) for quantitation of PXM in pharmaceutical formulations and biological samples.
Methods: Temperature-controlled ionic liquid dispersive liquid phase microextraction (TCIL-DLPME) was applied as
an environmentally friendly sample enrichment method to extract and isolate PXM prior to quantitation. Dispersion
of 1-hexyl-3-methylimidazolium hexafluorophosphate ([Hmim][PF6]) ionic liquid (IL) through the sample aqueous
solution was performed by applying a relatively high temperature. PXM was extracted into the extractor, and after
phase separation, PXM in the final solution was determined by stopped-flow injection spectrofluorimetry (SFIS).
Results and Major Conclusion: Different factors affecting the designed method such as IL amount, diluting agent,
pH and temperature were investigated in details and optimized. The method provided a linear dynamic range of
0.2-150 μg l-1, a limit of detection (LOD) of 0.046 μg l-1 and a relative standard deviation (RSD) of 3.1%. Furthermore,
in order to demonstrate the analytical applicability of the recommended method, it was applied for quantitation of
PXM in real samples.
Keywords: 1-Hexyl-3-methylimidazolium hexafluorophosphate, Stopped-flow injection spectrofluorimetry,
Pharmaceutical formulations, Biological samplesBackground
Piroxicam (PXM, 4-hydroxy-2-methyl-N-(pyridine-2-yl)-
2H-1, 2-benzo-thiazine-3-carboxamide-1,2-dioxide) belongs
to the wide class of non-steroidal anti-inflammatory and
analgesic drugs (NSAIDs) [1]. This drug has been widely
used to treat podagrous and rheumatoid arthritis, go-
narthrosis, osteoarthritis, backaches, neuralgia, mialgia,
and other diseases accompanied by the pain syndrome or
an inflammatory process [2,3]. To our knowledge, until* Correspondence: Zeeb.mohsen@gmail.com
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reproduction in any medium, provided the ornow, some analytical techniques such as high performance
liquid chromatography (HPLC) [4], capillary electrophor-
esis [5], liquid chromatography-mass spectrometry (LC/
MS) [6], spectrometry [7], electrochemistry [8] have been
reported for the quantitative analysis of PXM. The data
obtained in these works reveal that the sensitivity and se-
lectivity is not acceptable which is due to low amount of
analyte in real sample and matrix impact. Thus, develop-
ment and application of practical and benign sample pre-
treatment procedures prior to quantitation are important
tasks of chemists. Combination of sample enrichment pro-
cedures with inexpensive, selective and sensitive determin-
ation tools such as spectrofluorimetry makes it possible totd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ity and extremely reduce the cost of analysis.
Previous studies reveal that ionic liquids (ILs) are suitable
materials in sample enrichment procedures due to their
special properties [9]. One of the practical advantages of
ILs application in microextraction methods is the removal
of toxic extraction materials. The most popular extraction
techniques based on ILs are ionic liquid-based dispersive
liquid-liquid microextraction (IL-DLLME) [10-13], cold-
induced aggregation microextraction (CIAME) [14] and
temperature-controlled ionic liquid dispersive liquid phase
microextraction (TCIL-DLPME) [15].
In TCIL-DLPME procedure, dispersion of IL through
the sample aqueous solution is occurred by applying a
relatively high temperature. This phenomenon increases
the chance of analyte extraction into extractor phase. By
cooling the solution and centrifugation, it is possible to
collect the IL-phase and transfer it to analytical tool for
subsequent analysis. Based on the data obtained in our
previous works, the out put of ionic liquid-sample en-
richment methods meaningfully depends on variations
in the values of ionic strength [16-19]. It is obvious that
this factor can affect on the solubility of extractor. In
order to obtained stable results, a common ion of ex-
tractor solvent (PF6
- ) was dissolved in the studied solu-
tion. Using this way, the volume of the extractor was not
affected by changes occurred in the value of ionic
strength.
In this study, spectrofluorimetric method was utilized
for quantitation owning to some advantages including
good selectivity and sensitivity, low cost of analysis and
high response speed. To our knowledge, for the first
time, TCIL-DLPME was combined with stopped-flow in-
jection spectrofluorimetry (SFIS) for trace determination
of PXM. The factors influencing the proposed method
were studied in details and optimized. Finally, In order
to demonstrate the analytical advantage of TCIL-DLPME
-SFIS, It was utilized for quantitation of PXM in pharma-
ceutical and biological samples.Material and methods
Instrumentation
Fluorescence signals were recorded using FP-6200 spec-
trofluorimeter (JASCO Corporation, Tokyo, Japan). Xenon
discharge lamp, peristaltic sipper unit (model SHP-292),
and micro-cell (path length of 3 mm and volume of 15 μL)
were used as the accessories. The PC-based Windows®
Spectra Manager™ software was applied for recording and
processing of the analytical signals. A centrifuge was pur-
chased from Hettich (Tuttlingen, Germany) and used for
accelerating the phase separation. The pH-meter model
692 (Herisau, Switzerland) supplied with a glass-combined
electrode was used for pH measuring.Reagents and materials
Analytical-reagent grade of chemicals was used in all ex-
periments. All aqueous solutions were prepared using
ultra pure water. Piroxicam hydrochloride was obtained
from Alhavi Pharmaceutical Company (Tehran, Iran).
1-Hexyl-3-methylimidazolium hexafluorophosphate [Hmim]
[PF6], acetone, acetonitrile, methanol, ethanol, NH3, HCl,
NaOH and sodium hexafluorophosphate (NaPF6) were
purchased from Merck (Darmstadt, Germany). A stock
solution of 200 mg ml-1 of NaPF6 was obtained by dissolv-
ing required amount of NaPF6 in water. Piroxicam has a
low solubility in water (0.00004 M). Hence, a stock solu-
tion of piroxicam (1000 mg l-1) was obtained by dissolving
10 mg of pure drug in 10 ml of 5 M NH3. The obtained
stock solution was stored at 5°C in the dark until use.
Working solutions of lower concentrations were prepared
daily from the above stock solution as required. Piroxicam
capsules and tablets were obtained from a local pharmacy.
Microextraction procedure
In the presented microextraction procedure, aliquots of
10.0 ml sample solution (pH = 3) containing PXM in the
concentration range of 0.2-150 μg l-1 were placed into a
screw-glass test tube with conic bottom. Then, 55 mg of
[Hmim][PF6] IL and 0.9 ml of NaPF6 (200 mg ml
-1) was
added. After shaking, the conical tube was heated in a
water bath with the temperature controlled at 40 °C for
5 min. Under this condition, the extractor was dissolved
completely and the PXM was effectively extracted into
the IL phase. After this step, the resulting solution was
placed in ice-water bath and cooled for 7 min. After this
process, a turbid condition was formed due to the de-
crease of the solubility of the extractor. The obtained so-
lution was centrifuged for 5 min at 4000 rpm. The
aqueous phase was removed using a proper syringe. For
conditioning the extractor prior to quantitation by SFIS,
the residue in the vessel was diluted to 250 μL by adding
required amount of ethanol. Finally, the diluted IL-phase
in the vessel was transferred to the spectrofluorimeter
by the peristaltic sipper unit.
Stopped-flow injection spectrofluorimetry
In the presented work, fluorescence signals were re-
corded using stopped-flow injection technique. In order
to apply stopped-flow injection mode, a peristaltic sipper
unit supplied with a 15 μL quartz micro-cell was utilized
to increase the speed of measurement and significantly
reduce the required volume of the extractor. In order to
control the enriched phase uptake, the rotation time of
the peristaltic pump was changed. For transferring the
extraction solvent to the spectrofluorimeter, the tube of
the peristaltic pump unit was placed into the sample
vessel, and suction step was started for 0.4 s. After this
process, IL-phase was introduced to the 15 μL micro-
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delay time, the rotation of peristaltic pump was stopped.
The stopped time was applied for 2 s, in order to obtain
a stable experimental condition prior to quantitation.
Fluorescence signal was recorded at 455 ± 5 nm. The ex-
citation wavelength was fixed at 320 ± 5 nm. Schematic
diagram of stopped-flow injection spectrofluorimetry ap-
plied in the present study is shown in Figure 1.
Preparation of pharmaceutical formulations and
biological samples
In order to obtain analyzable pharmaceutical solution, six
piroxicam capsules or powdered tablets were entirely
mixed, and afterwards a proper amount of powder con-
taining 10 mg of PXM was dissolved in 5 M NH3. To pre-
pare a clear solution, the resulting sample was filtered into
a 100 ml volumetric flask by Whatman No. 42 filter paper,
and made up to the mark using ultra pure water. Prior to
quantitation, a proper dilution was performed, in order to
ensure the concentration of the pharmaceutical solution
was in the dynamic range.
In order to obtain analyzable human plasma samples, 1.0
ml of this real sample were spiked with PXM and
deproteinized by addition of 5 ml acetonitrile. After this
process, the resulting biological real sample was centrifuged
at 4000 rpm for 15 min, and 2.0 ml of the clear upper pahse
was diluted to 100 ml. Aliquot of 10 ml of this sample was
utilized for each test. 10 ml of human urine samples were
transferred into centrifuge tubes. Urine samples were
centrifuged for 4 min at 4000 rpm. Afterwards, aliquots of
2 ml from clear upper phase were transferred into new cen-
trifuge tubes, spiked with different concentrations of PXM
and diluted to 20 ml. In order to determine the trace levels
of PXM, aliquot of 10 ml of this solution was subjected to
TCIL-DLPME-SFIS.Figure 1 (A) Schematic diagram of SFIS (B) Structure of peristaltic sip
5 nm; suction time 0.4 s; transferring time 1 s; delay time 2 s.Results and discussion
In the recommend method, an efficient sample pretreat-
ment method called temperature-controlled ionic liquid dis-
persive liquid phase microextraction (TCIL-DLPME) was
followed by stopped-flow injection spectrofluorimetry (SFIS)
for preconcentration and trace level determination of PXM
in real samples. To achieve a proper efficiency and stabil-
ity, different variables affecting the recommended method
were studied and optimized. Pre-concentration factor (PF)
was evaluated according to the following equation:
PF ¼ Csed
C0
In this equation, Csed and C0 show the concentration
of PXM in the enriched phase and initial concentration
of PXM in the aqueous phase, respectively. Csed, for ex-
tractor solvents and diluting agents, was measured using
the calibration graph obtained from direct injection of
PXM in enriched phase.
Spectrofluorimetric calibration curve and spectral
characteristics
Since PXM has a cyclic conjugated structure, this com-
pound shows considerable fluorescence signal. The emis-
sion spectra of 6 standard solutions of PXM with different
concentrations in the range of 0.2-150 μg l-1 were re-
corded using TCIL-DLPME-SFIS (see Figure 2). Fluores-
cence signal was recorded at 455 ± 5 nm. The excitation
wavelength was fixed at 320 ± 5 nm. To achieve stable, re-
producible and accurate data, the reagent blank must have
no measurable impact on the fluorescence signal of PXM.
Hence, the sample enrichment procedure was applied for
reagent blank using the mentioned excitation and emis-
sion wavelengths. The data obtained in this test shown noper unit. Utilized experimental conditions: λex 320 ± 5 nm; λem 455 ±
Figure 2 Fluorescence spectra obtained for 6 standard solutions of PXM with different concentrations (0.2, 10, 50, 75, 125, 150 μg l-1).
Utilized experimental conditions: Sample volume 10 ml; [Hmim][PF6] 55 mg; NaPF6 180 mg; pH 3; temperature 40°C; centrifugation time 5 min.
λex 320 ± 5 nm; λem 455 ± 5 nm. Inset: Calibration curve and corresponding equation in the linear range of analytical signals.
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selected for the rest of the work.Selection of IL
Following consideration can ease the selection of IL: (a)
the density of extractor must be higher than aqueous
phase, (b) extractor must be liquid through the experi-
ments, (c) IL must show proper hydrophobic manner
and (d) IL must be certainly inexpensive. ILs containing
(CF3SO2)2N
− are relatively expensive and those containing
PF6
- are relatively inexpensive. According to the mentioned
points, [Hmim][PF6] was selected as a microextraction
solvent in all experiments.Type of diluting agent
Kind of diluting agent is one the important factors in
TCIL-DLPME. Since the density of ionic liquid is rela-
tively high, this extractor must be diluted prior to trans-
fer and quantitation. In the present test, some organic
diluting agent involving methanol, ethanol, acetone and
acetonitrile were investigated. Because of the better per-
formance of ethanol and its better safety, this diluting
material was utilized in all the tests.Influence of IL amount
In this investigation, the influence of [Hmim][PF6] a-
mount on the TCIL-DLPME and subsequent analytical
signals was tested. The influence of this factor was tested
within the range of 10–120 mg (Figure 3). Stable data
were achieved at 55 mg of IL. When a larger amount of
extractor to be used, the volume of the enriched phase
increases and the signal intensity decreases. As a result,55 mg of extractor was selected as an optimum value
and used in the following experiments.
Influence of common ion amount and ionic strength
Based on the results obtained in our previous works, dis-
solving a common ion of extractor can provide more
stable dada. As it was described, this act can decrease
the solubility of the extraction phase and provide better
sensitivity. For this evaluation, NaPF6 was applied in all
tests a common ion source. The impact of this factor
was tested in the range of 0–300 mg. Figure 4 show the
obtained results in this experiment. A better stability
was achieved at 180 mg. Therefore, this amount was
applied for the rest of the work.
Based on the results obtained in our previous studies,
in traditional sample enrichment methods based on ILs,
the volume of remaining enriched phase depends on the
value of the ionic strength. As it was explained above, in
order to overcome this phenomenon, a common ion of
extractor phase was dissolved in the sample under study.
NaNO3 was utilized as an electrolyte to test the impact
of this factor. This factor was carefully evaluated over
the range of 0–35% (w/v) and no measurable impact was
observed in this range.
Influence of pH
The pH of the sample solution plays a critical role in the
extraction of ionizable organic molecules such as PXM.
The influence of this factor on the microextraction of
PXM was evaluated within the range of 1–8 using HCl
and NaOH. The best data is obtained at pH values where
the uncharged condition of the compound of interest is
prevalent. The reported acidic constants for PXM are pKa1
= 1.81 and pKa2 = 5.12 [20]. Figure 5 shows a possible
Figure 3 Effetc of IL amount. Utilized experimental conditions: Sample volume 10 ml; PXM concentration 75 μg l-1; NaPF6 180 mg; pH 3;
temperature 40°C; centrifugation time 5 min. λex 320 ± 5 nm; λem 455 ± 5 nm.
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zwitterion (LH±). The variation of analytical signals versus
pH revealed that a better extraction was obtained at pH 3
(Figure 6). Thus, pH 3 was used in the following study.
Influence of temperature
Complete dispersion of IL-phase in the sample solution is
occurred by applying a relatively high temperature. The
obtained data revealed that the solubility of extractor at
temperature above 30°C significantly increased. A series
experiments were performed in order to optimize the
temperature in the range of 30–70°C. A better stability andFigure 4 Effect of common ion. Utilized experimental conditions: Sample
temperature 40°C; centrifugation time 5 min. λex 320 ± 5 nm; λem 455 ± 5sensitivity was obtained at 40°C, therefore this temperature
was used an optimum value. In the next step, sample solu-
tions were cooled in the temperature range of 0-25°C. By
applying a low temperature, the analytical sensitivities im-
prove which is due to the solubility decrease of extractor
phase at low temperatures. Hence, a temperature of 0°C
was utilized through the rest of the work.
Influence of centrifuge conditions
In this experiment, the impact of this factor on the sen-
sitivity and reproducibility was tested in the range of
1000–6000 rpm. In order to settle the extractor phase,volume 10 ml; PXM concentration 75 μg l-1; [Hmim][PF6] 55 mg; pH 3;
nm.
Figure 6 Effect of pH. Utilized experimental conditions: Sample volume 1
temperature 40°C; centrifugation time 5 min. λex 320 ± 5 nm; λem 455 ± 5
Figure 5 Equilibrium of PXM between the neutral molecule
(LH0) and the zwitterion (LH±).
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optimum value. After this study, the impact of centrifu-
gation time on the sensitivity and stability of signals was
tested. After 4 min, no measurable change was observed.
As a result, 5 min was selected as the centrifugation
time. Table 1 shows the tested and selected experimental
conditions.
Selectivity of the method
In the present study, in order to demonstrate the select-
ivity of the method, the impact of some possible interfer-
ing substances such as Na+, Ca2+, Zn2+, Mg2+, Cl-, PO4
3-,
SO4
2-, citric acid, starch, glucose, lactose, sucrose, ascor-
bic acid, uric acid, oxalic acid and lactic acid on the de-
termination of PXM at 75 μg L-1 was tested. 100-fold
the mentioned substances have no observable impact on
the fluorescence responses (fluorescence response change
below 5%).
Method evaluation
In order to obtain calibration graph and linear dynamic
range, different concentrations of PXM standard solutions
were subjected to TCIL-DLPME-SFIS. The designed me-
thod provided a linear dynamic range of 0.2-150 μg l-1
PXM. Analytical performance of the combined method-
ology is summarized in Table 2. The limit of detection
(LOD) of TCIL-DLPME-SFIS was defined using the fol-
lowing equation:
LOD ¼ ksbl=m:
In the mentioned equation, the value of K is 3, sbl
shows the standard deviation of the blank signals and m0 ml; PXM concentration 75 μg l-1; [Hmim][PF6] 55 mg; NaPF6 180 mg;
nm.










Human plasma 0.0 - - -
5.0 4.8 96 4.0
75.0 73.2 97.6 3.3
150.0 148.3 98.9 3.9
Human urine 0.0 - - -
5.0 5.2 104 3.0
75.0 72.8 97.1 3.1
150.0 144.0 96 4.3
Prioxicam capsule 0.0 9.6 - -
5.0 14.3 97.9 3.9
75.0 80.6 95.3 3.2
150.0 147.1 98.1 3.0
Prioxicam tablet 0.0 9.7 - -
5 14.0 95.2 4.2
75.0 80.9 95.5 3.0
150.0 146.3 97.5 4.7
a The illustrated results correspond to the average of three
independent measurements.






Amount of [Hmim][PF6] ionic liquid (mg) 10-120 55
Amount of common ion (NaPF6) (mg) 0-300 180
pH 1-8 3
Temperature (°C) 30-70 40
Centrifugation rate (rpm) 1000-6000 4000





Suction time (s) 0.1-3 0.4
Transferring time (s) 0.1-3 1
Delay time (s) 0.1-4 2
Excitation wavelength (nm) 200-400 320 ± 5
Emission wavelength (nm) 410-700 455 ± 5
Excitation and emission slit widths (nm) 5-20 10
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was 0.046 μg l-1. In order to define the repeatability of
the designed system, four 75 μg l-1 standard solutions of
PXM were analyzed and by this way the relative stand-
ard deviation (RSD) was 3.1%.
Analysis of PXM in real samples
The analytical applicability of the designed TCIL-
DLPME-SFIS was tested by the quantitation of PXM in
the spiked human urine and spiked human plasma.
These data are summarized in Table 3. These tests re-
vealed that the mean recoveries of PXM in studied real
biological samples were in the range of 96–103% and
95.2-104% for plasma and urine samples, respectively.
The obtained data demonstrated the acceptable accuracy
and precision of the designed methodology. In the next
experiments, the proposed technique was utilized for theTable 2 Analytical performance of the proposed
methodology
Analytical parameter Performance
Dynamic range (μg L-1) 0.2-150
Correlation coefficient (R2) 0.9992
LODa (μg L-1) 0.046
RSDb (%) (n = 4 ) (CPXM = 75 μg L-1) 3.1
PFc (CPXM = 75 μg L
-1) 31.2
Sample volume (mL) 10
Temperature (°C) 40
a Limit of detection.
b Relative standard deviation.
c Preconcentration factor.quantitation of PXM in pharmaceutical formulations in-
cluding tablets and capsules. The obtained data are
shown in Table 3. The recent data show the validity of
the designed TCIL-DLPME-SFIS for the determination
of PXM in pharmaceutical formulations.
Conclusion
In this study, a benign and simple sample enrichment
method called temperature- controlled ionic liquid dis-
persive liquid phase microextraction (TCIL-DLPME)
was followed by stopped-flow injection spectrofluori-
metry (SFIS) for quantitation of piroxicam in pharma-
ceutical and biological samples. Ionic liquid was used an
extractor instead of toxic solvents, in order to protect
the environment against harmful material and provide a
better safety for chemists during the experiments. Trad-
itional sample enrichment methods based on the appli-
cation of ionic liquid suffer from some limitations such
as the dependence of extraction efficiency on ionic
strength values. To remove the latter problem, the
microextraction procedure was assisted by a common
ion of extractor. The application of stopped-flow injec-
tion mode makes it possible to increase the speed of
quantitative measurements, decrease the required
enriched phase and provide a better reproducibility and
automation. Fluorimetry was applied as a determination
technique because of some advantages including good
selectivity and sensitivity, low cost of analysis and high
response speed. For quality control of PXM, the present
Zeeb et al. DARU Journal of Pharmaceutical Sciences 2013, 21:63 Page 8 of 8
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sive analytical tool.
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